Catheter Precision (VTAK) Net Margin (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Net Margin data on file, last reported at 703.94% in Q1 2026.

• On a quarterly basis, Net Margin rose 212474.0% year-over-year to 703.94% in Q1 2026; TTM through Mar 2026 was 1083.66%, a 200823.0% increase from a year earlier, with the FY2025 full-year figure at 2098.05%, up 309267.0% from the prior year.
• Net Margin for Q1 2026 stood at 703.94%, down from 155.46% in the prior quarter.
• Over the last five years, Net Margin for VTAK reached as high as 77.41% in Q1 2022 and fell as low as 79258.82% in Q1 2023.
• Historically, Net Margin has averaged 6963.61% across 5 years, with a median of 1641.67% in 2023.
• Across the five-year window, Net Margin plunged 7918141 bps in 2023 and surged 7599663 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 198.12% in 2022, then sank by 97 bps to 389.84% in 2023, then plunged by 328 bps to 1669.13% in 2024, then surged by 91 bps to 155.46% in 2025, then tumbled by 353 bps to 703.94% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 703.94% in Q1 2026, 155.46% in Q4 2025, and 968.14% in Q3 2025.